Atrial Fibrillation in COVID-19: From Epidemiological Association to Pharmacological Implications
- PMID: 32453074
- DOI: 10.1097/FJC.0000000000000854
Atrial Fibrillation in COVID-19: From Epidemiological Association to Pharmacological Implications
Abstract
Coronavirus disease 2019 (COVID-19) outbreak is a public health emergency of international concerns because of a highly pathogenic human coronavirus (HCoV), actually named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite much emerging data about the epidemiological association between cardiovascular diseases and COVID-19, little is still known about atrial fibrillation and its optimal management in this clinical contest. The aim of our review is to describe the pharmacological interactions between cardiovascular drugs more commonly used in atrial fibrillation management and experimental COVID-19 therapies, based on EU and US summaries of product characteristics.
Comment in
-
Choosing Wisely: Cardiovascular Drug Therapy in the Era of COVID-19.J Cardiovasc Pharmacol. 2020 Aug;76(2):123-124. doi: 10.1097/FJC.0000000000000875. J Cardiovasc Pharmacol. 2020. PMID: 32776770 No abstract available.
References
-
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
-
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069.
-
- Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020;133:1025–1031.
-
- Chen C, Chen C, Yan JT, et al. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19 [in Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48:E008.
-
- Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020. doi: 10.1001/jama.2020.4683. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous